|
End-of-day quote
Buenos Aires S.E.
15/09/2026
|
5-day change | 1st Jan Change | ||
| 155.00 ARS | +1.64% |
|
+0.65% | -35.55% |
| Market Cap | 6.6B 4.38M 3.79M 3.59M 3.25M 6.09M 420M 6.14M 42.8M 16.47M 213M 16.45M 16.08M 679M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.34B 4.87M 4.22M 3.99M 3.61M 6.77M 467M 6.83M 47.58M 18.31M 237M 18.28M 17.88M 755M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.64% | ||
| 1 week | +0.65% | ||
| Current month | -4.32% | ||
| 1 month | -0.64% | ||
| 3 months | -3.43% | ||
| 6 months | -19.69% | ||
| Current year | -35.55% |
| 1 week | 149 |  | 158 |
| 1 month | 149 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 29.6 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 29/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 29/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.64% | +0.65% | +0.98% | +421.89% | 4.38M | |
| -0.33% | -0.18% | -49.79% | -59.26% | 30.34B | |
| -0.65% | -4.05% | +23.39% | +91.83% | 11.49B | |
| -2.81% | -5.90% | -14.26% | -0.36% | 3.81B | |
| -0.95% | +1.30% | -0.48% | +21.17% | 3.05B | |
| -1.27% | -5.88% | +32.54% | +23.44% | 1.9B | |
| +0.73% | +0.58% | +12.32% | +45.78% | 1.86B | |
| -2.53% | -6.11% | -11.38% | +177.58% | 1.42B | |
| -0.58% | -4.91% | -21.61% | -6.56% | 1.17B | |
| +0.13% | +14.44% | -4.99% | -5.82% | 1.02B | |
| Average | -0.75% | -1.08% | -3.33% | +70.97% | 5.61B | |
| Weighted average by Cap. | -1.14% | -1.52% | -22.47% | -5.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.49M 4.75M 4.5M 4.07M 7.64M 526M 7.7M 53.65M 20.64M 267M 20.62M 20.16M 851M | 6.4B 4.25M 3.68M 3.48M 3.15M 5.91M 407M 5.96M 41.51M 15.97M 207M 15.95M 15.6M 659M |
| Net income | -1.42B -940K -814K -770K -697K -1.31M -90.18M -1.32M -9.19M -3.54M -45.72M -3.53M -3.45M -146M | -4.6B -3.05M -2.64M -2.5M -2.26M -4.24M -293M -4.28M -29.81M -11.47M -148M -11.45M -11.2M -473M |
| Net Debt | 863M 573K 496K 469K 425K 797K 54.92M 803K 5.6M 2.15M 27.85M 2.15M 2.1M 88.81M | 738M 489K 424K 401K 363K 681K 46.94M 686K 4.78M 1.84M 23.8M 1.84M 1.8M 75.9M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | ARS 155.00 | +1.64% | 12,950 |
| 14/09/26 | ARS 152.50 | -2.87% | 47,647 |
| 11/09/26 | ARS 157.00 | +1.29% | 5,158 |
| 10/09/26 | ARS 155.00 | +0.65% | 8,234 |
| 09/09/26 | ARS 154.00 | 0.00% | 6,213 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
